Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Feb 8, 2016
Insider Transaction Report
Form 4
Ahn Edward S.
Chief Tech. & Strategy Officer
Transactions
- Award
Common Stock
2016-02-04+7,900→ 7,900 total - Award
Stock Option (Right to Buy)
2016-02-04+18,300→ 18,300 totalExercise: $38.11Exp: 2026-02-04→ Common Stock (18,300 underlying)
Footnotes (2)
- [F1]Restricted stock awards vest in four equal annual installments beginning February 4, 2017.
- [F2]The stock options vest in four equal annual installments beginning February 4, 2017.